chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Alanine aminotransferase normal, Antineutrophil cytoplasmic antibody, Aspartate aminotransferase normal, Asthenia
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood alkaline phosphatase normal, Blood bilirubin normal, Blood chloride increased, Blood creatinine increased, Blood glucose normal
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid, Blood magnesium normal, Blood potassium increased, Blood sodium normal, Blood urea increased
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Brain natriuretic peptide increased, C-reactive protein increased, COVID-19, Carbon dioxide decreased, Cardiac sarcoidosis
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chills, Condition aggravated, Drug trough level, Dyspnoea
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2, Fibrin D dimer, Full blood count abnormal, Haemofiltration, Haemoglobin decreased
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Heart transplant, Hyperkalaemia, Hypoxia, Immunosuppressant drug therapy, Infection
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio increased, Liver function test normal, Lung assist device therapy, Lung opacity, Mean cell volume normal
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Neutrophil count, Pancytopenia, Platelet count decreased, Platelet-large cell ratio, Pneumonia
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Positron emission tomogram, Prothrombin time prolonged, Pyrexia, Respiratory failure, Right ventricular dysfunction
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Tachycardia, Thrombocytopenia, Troponin
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary sediment, Urine analysis, White blood cell count decreased
Clinical narrative: 61 yo man w/PMH of HTN, HLD, pulmonary sarcoidosis, sarcoid CM s/p heart transplant (5/11, c/b RV dysfunction requiring ECMO and CRRT), CKD, recent admission (9/10-9/14 for AKI, concern for rejection), COVID + (11/26/21) after exposure on 11/24, presenting with fevers/chills, shortness of breath, weakness. S/p regeneron 12/1/21, transferred for further care.  Per chart review - febrile, tachycardic, hxpoxemic initially, LA initially 6.3, but cleared with IVFs.  Started on HFNC initially but able to de-escalate to regular NC.  Started decadron, remdesevir.  Continued on transplant meds.  Empiric coverage with CTX/Doxy. Hypoxic resp failure/Covid+ve PNA/Sepsis --Covid +11/26 with isolation to end 12/17 per ID --Decadron 6mg IV transitioned back to to prednisone 10 mg daily --s/p remdesivir therapy #Pancytopenia: probable covid related --Last received Zarxio 480mcg 12/8/2021 --WBC improved ANC currently stable --continue Valcyte - ýChange Pepcid to protonix --hold ASA --monitor platelets closely S/p orthotopic heart transplant 5/11/2021 for cardiac sarcoidosis.  - prograf/mmf/pred immunosuppression regimen.  --Celcept reduced given infection, will need to readjusted later --Continue Prograf and follow daily levels Goal trough 8-10 (6-12 months);ýlevel stable --Continue Cellcept 250 mg BID, Prednisone 10 mg dailyýýý -- Hydralazine 25 mg TID AKI with hyperkalemia --continue Patiromirý --continue to encourage PO fluid ýý Sarcoidosis - prednisone taper as above - repeat PET scan 6 months post transplant (~11/11/2021) - overdue; will do as outpatient - ACE levels q 3 months . ýNext in Jan ý
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: BUD for vaccine was 12/18, vaccine was administered on 12/19. expiration date on vial was 02/2022.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dry skin, Skin warm
Clinical narrative: attendee states she felt a little light headed, skin warm and dry, VS within normal range, declined further VSigns and left without incident after education given
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Immediate post-injection reaction
Clinical narrative: Immediately after vaccination @14:25 pt reported dizziness.  Vitals: 109/72, 70, 16 Pt stable and released from the vaccination site.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Haemophilus infection, Haemophilus test positive, Influenza
Clinical narrative: Pt received two Pfizer Covid vaccines in April 2021. She noted cough and fever and tested COVID positive as an outpatient on 12/13/21. She received monoclonal antibody therapy at the local HCF, on 12/15/21. However, her symptoms were not getting better, and she was admitted to another local hospital on 12/18/21. She was also tested Influenza A PCR positive and blood culture positive with Haemophilus influenzae DNA upon admission. She is still febrile but not on oxygen. Hospital Day 3, she is receiving Cetriaxone, Dexamethasone, Oseltamivir, and Remdesivir.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Influenza A virus test positive, Pyrexia, SARS-CoV-2 test positive, Viral test positive
Clinical narrative: Pt received two Pfizer Covid vaccines in April 2021. She noted cough and fever and tested COVID positive as an outpatient on 12/13/21. She received monoclonal antibody therapy at the local HCF, on 12/15/21. However, her symptoms were not getting better, and she was admitted to another local hospital on 12/18/21. She was also tested Influenza A PCR positive and blood culture positive with Haemophilus influenzae DNA upon admission. She is still febrile but not on oxygen. Hospital Day 3, she is receiving Cetriaxone, Dexamethasone, Oseltamivir, and Remdesivir.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pt was administered a booster dose at this time on 12/18/21 and was discovered after the injection they were not 16 years old. They are 15 years and 4 months.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Anaemia, Platelet count decreased, Purpura, Thrombocytopenia, Vaginal haemorrhage
Clinical narrative: Severe thrombocytopenia anemia platelet count of 8k severe vaginal bleeding and skin pupura
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Biopsy breast abnormal, Breast cancer female, Central venous catheterisation, Chemotherapy, Computerised tomogram
Clinical narrative: I have had a fibroadenoma in my right breast since  I was 18 years old  After the Covid shot I found it to be growing and changing in size  I completed a herbal cleanse in May 2021 and the fibroadenoma decreased in size  After the cleanse a few months later the fibroadenoma began changing and growing again  At this point I went for a mammogram and ultrasound followed by a  biopsy  I was diagnosed with breast cancer on November 23rd 2021
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Condition aggravated, Fibroadenoma of breast, Magnetic resonance imaging breast, Mammogram abnormal, Ultrasound breast abnormal
Clinical narrative: I have had a fibroadenoma in my right breast since  I was 18 years old  After the Covid shot I found it to be growing and changing in size  I completed a herbal cleanse in May 2021 and the fibroadenoma decreased in size  After the cleanse a few months later the fibroadenoma began changing and growing again  At this point I went for a mammogram and ultrasound followed by a  biopsy  I was diagnosed with breast cancer on November 23rd 2021
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Headache
Clinical narrative: The next morning at 4:00AM, 16 hours after the vaccination I had weakness, headache, and tiredness.
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic shock, Dyspnoea, Hyperhidrosis, Pallor, Swelling
Clinical narrative: Pt presented for J&J vaccination on 5/28/21. Patient had a severe anaphylactic shock with MODERNA vaccine on January 15, 2021. Patient received the first dose in regional hospital. Patient states that he had SOB, hives, swollen body, wheezing, diaphoresis, and became pale. He was quickly rushed to the ER and received IV Benadryl and Solumedrol (4x the night).
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Urticaria, Wheezing
Clinical narrative: Pt presented for J&J vaccination on 5/28/21. Patient had a severe anaphylactic shock with MODERNA vaccine on January 15, 2021. Patient received the first dose in regional hospital. Patient states that he had SOB, hives, swollen body, wheezing, diaphoresis, and became pale. He was quickly rushed to the ER and received IV Benadryl and Solumedrol (4x the night).
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Unevaluable event
Clinical narrative: na
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: No adverse events have been reported. Patient's vaccine was past the beyond-use-date by approximately 10 hours due to being refrigerated for over 30 days. The beyond-use-date was not noted until 2-3 hours after vaccination. Pharmacy left a message with the patient, but has not spoken with him yet.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given an expired Moderna vaccine.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Angioedema, Burning sensation, Pruritus, Rash erythematous, Rash papular
Clinical narrative: Symptoms started as the severe itching/burning sensation on the hands and feet with red raised skin wheals. Symptoms progressed after one week into daily severe hives and itching on the whole body especially on the upper body part :face ; neck; scalp; Another daily symptoms I experience are angioedema of the  face especially of the  lips and nose as well as throat closing sensation;
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Throat tightness, Urticaria
Clinical narrative: Symptoms started as the severe itching/burning sensation on the hands and feet with red raised skin wheals. Symptoms progressed after one week into daily severe hives and itching on the whole body especially on the upper body part :face ; neck; scalp; Another daily symptoms I experience are angioedema of the  face especially of the  lips and nose as well as throat closing sensation;
Age: 13.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, Electrocardiogram abnormal, Pain, Painful respiration, Pericarditis
Clinical narrative: After my daughter received her second shot on 10/10/2021 she woke up around midnight and stated that it hurt to breathe.  So we had her take a shower, take some Tylenol and take a nebulizer treatment to try help her lungs open up.  After doing this it didn't help but she was able to fall back to sleep on and off. I did take her to the ER the next day because her pediatrician stated to go there.  When we got the ER which after only 45 minutes then sent us home and said it was nothing to worry about.  She wasn't getting any better so on 10/12/2021 I brought her to the walk in clinic for hospital for a second option. They stated that they couldn't read what ever ER wrote for the EKG so they were going back and forth with the ER's trying to figure out what we should do.  After listening to her and trying to read the EKG they had thought that the wall of the heart was was swollen and said we could go home but they made an appointment for her to see a Cardiologist at Hospital.  When we saw MD, he also stated that he couldn't read ER's EKG so he would have to do another one.  After reading the EKG that he ran he did state that he did believe that the wall around he heart was swollen.  He stated that it is a rare case that it happens in girls because they have been seeing it more in boys.  He also said that it should heal on it's own but could take a few weeks to a month to heal.  After about 3 weeks it did seem to go away but about once a week to every other week she will get some pains and says it is hard to breathe again.   This will last a few minutes to a few hours and then goes away.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site nodule, Injection site pain
Clinical narrative: Knot in upper right arm where shot was given. It also burned a little bit a week later.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Biopsy skin abnormal, Blood test normal, Dermatitis, Pruritus, Rash
Clinical narrative: Complains of constant itching all over his body.  States has small "bumps" all over his back. (sample/ biopsy taken and results note ectopic dermatitis)
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Fatigue, Tremor
Clinical narrative: I had no adverse reactions to the first injection of the Moderna vaccine. I had only mild fatigue the day after my second injection of the Moderna vaccine. The third injection caused a strong reaction approximately 44 hours after the injection. Strong chills and shakes accompanied by stomach cramps and fatigue which lasted over 2 days.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Borrelia test, Chills, Deep vein thrombosis, Fatigue
Clinical narrative: First 48 hours headache, chills hot and cold fatigue. Felt better but never felt right , felt off for months tested for lime , couldn?t pinpoint what was wrong. In the beginning of November starter to have pain in my hip area went on for 3 weeks on the night of the 26 couldn?t sleep all night from pain in the hip area .when I woke up on the 27 of November I looked down at my legs ,my left leg was 3 times bigger than my right . I went to the ER in my local hospital and ther admitted me , I had a DVT . I had surgery on the 28 to remove the blood cloths ,  was sent home on the 29 ,leg was still huge could not walk . Next day called doctors office and was seen , was sent back to hospital,the blood cloths had returned ,had surgery on the 1 Of December had surgery also the 2 of December had surgery.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Feeling of body temperature change, Gait inability, Headache, Peripheral swelling
Clinical narrative: First 48 hours headache, chills hot and cold fatigue. Felt better but never felt right , felt off for months tested for lime , couldn?t pinpoint what was wrong. In the beginning of November starter to have pain in my hip area went on for 3 weeks on the night of the 26 couldn?t sleep all night from pain in the hip area .when I woke up on the 27 of November I looked down at my legs ,my left leg was 3 times bigger than my right . I went to the ER in my local hospital and ther admitted me , I had a DVT . I had surgery on the 28 to remove the blood cloths ,  was sent home on the 29 ,leg was still huge could not walk . Next day called doctors office and was seen , was sent back to hospital,the blood cloths had returned ,had surgery on the 1 Of December had surgery also the 2 of December had surgery.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sleep disorder, Thrombectomy
Clinical narrative: First 48 hours headache, chills hot and cold fatigue. Felt better but never felt right , felt off for months tested for lime , couldn?t pinpoint what was wrong. In the beginning of November starter to have pain in my hip area went on for 3 weeks on the night of the 26 couldn?t sleep all night from pain in the hip area .when I woke up on the 27 of November I looked down at my legs ,my left leg was 3 times bigger than my right . I went to the ER in my local hospital and ther admitted me , I had a DVT . I had surgery on the 28 to remove the blood cloths ,  was sent home on the 29 ,leg was still huge could not walk . Next day called doctors office and was seen , was sent back to hospital,the blood cloths had returned ,had surgery on the 1 Of December had surgery also the 2 of December had surgery.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: First 48 hours headache, chills hot and cold fatigue. Felt better but never felt right , felt off for months tested for lime , couldn?t pinpoint what was wrong. In the beginning of November starter to have pain in my hip area went on for 3 weeks on the night of the 26 couldn?t sleep all night from pain in the hip area .when I woke up on the 27 of November I looked down at my legs ,my left leg was 3 times bigger than my right . I went to the ER in my local hospital and ther admitted me , I had a DVT . I had surgery on the 28 to remove the blood cloths ,  was sent home on the 29 ,leg was still huge could not walk . Next day called doctors office and was seen , was sent back to hospital,the blood cloths had returned ,had surgery on the 1 Of December had surgery also the 2 of December had surgery.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: No adverse events occurred.  We had a Moderna Covid-19 Vaccine reach its beyond use date due to being under refrigeration for 30 days on 12/19/2021. On the morning of 12/20/2021, the patient received the vaccine that was roughly 10 hours beyond use. The beyond use date was clearly marked on the package, but our pharmacy has never had a vaccine reach expiration date, and it was not until after the vaccine was given that the beyond use date was noticed.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal abscess, Abdominal discomfort, COVID-19 pneumonia, Hypoxia, Pancytopenia
Clinical narrative: DX COVID pneumonia and hypoxia. Pancytopenic.   Abdominal discomfort.  Abdominal abscess.   Treatment: remdesivir and decadron
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Ageusia, Anosmia, COVID-19, Chest pain, Cough
Clinical narrative: Tuesday, 12/14/2021 patient developed cough, shortness of breath, and constant chest pain. Patient also endorses loss of taste and smell at that same time.
Age: 50.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dyspnoea, SARS-CoV-2 test positive
Clinical narrative: Tuesday, 12/14/2021 patient developed cough, shortness of breath, and constant chest pain. Patient also endorses loss of taste and smell at that same time.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Gait disturbance, Peripheral swelling, Urticaria
Clinical narrative: 11-26-21 Pt experienced hives occurred all over the body, one foot swelled up and pt had difficulty walking. 11-27-21 Pt went to his doctor and received diphenhydramine, IM steroids, and an oral steroid
Sex: U
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: On 12/17/2021, the Covid Nurse for Community Clinic notified the Director Health Clinics, that the PA at the other Clinic has been keeping open vaccines vials for 5 days after the initial puncuture date. Accodring the CDC and Moderna guidance the vial is only to be keep for 12 hours after the puncture time. The PA was keeping them for 5 days. After initial interviews  and findings we have a possible 48 patients that might have been affected by this stanard of practice.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial fibrillation, Echocardiogram abnormal, Electrocardiogram abnormal
Clinical narrative: new onset atrial fibrillation with rapid ventricular response
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID +
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: No adverse events occurred.  We had a Moderna Covid-19 Vaccine reach its beyond use date due to being under refrigeration for 30 days on 12/19/2021. On the morning of 12/20/2021, the patient received the vaccine that was roughly 10 hours beyond use. The beyond use date was clearly marked on the package, but our pharmacy has never had a vaccine reach expiration date, and it was not until after the vaccine was given that the beyond use date was noticed.
Age: 35.0
Sex: F
Vaccine: TDAP
Symptoms: Administration site induration, Administration site reaction, Fatigue, Injection site pain, Malaise
Clinical narrative: Tdap had been accidentally adminstered rather than Tb for TB skin test.  Patient developed a local reaction to site of administration, a 6cm diameter area of erythematous tender swelling with very firm ~1cm diameter area of central induration on mid-third of right volar forearm.  She also reported increased fatigue and malaise. Symptoms developed within 12 hours of administration and began to resolve within 48 hours. Erythema, fatigue, malaise resolved, but induration still present one week post-administration.
Age: 35.0
Sex: F
Vaccine: TDAP
Symptoms: Rash erythematous, Wrong product administered
Clinical narrative: Tdap had been accidentally adminstered rather than Tb for TB skin test.  Patient developed a local reaction to site of administration, a 6cm diameter area of erythematous tender swelling with very firm ~1cm diameter area of central induration on mid-third of right volar forearm.  She also reported increased fatigue and malaise. Symptoms developed within 12 hours of administration and began to resolve within 48 hours. Erythema, fatigue, malaise resolved, but induration still present one week post-administration.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site rash, Pyrexia, Rash
Clinical narrative: 102 degree fever lasting 24 hours, rash at injection site, up and down arm, around neck area  and upper chest area.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough Case
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris, Cardiac disorder, Chills, Electrocardiogram ambulatory normal, Electrocardiogram normal
Clinical narrative: Other than getting severely sick with flu like symptoms (fever, aches, chills, extreme fatigue) - the sickest I have been in YEARS which lasted several days, I have had ongoing issues with my heart ever since.  Aching, odd sensations occurring there at any time of day, under any type of activity - even laying in bed & it will wake me up from my sleep at times.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Illness, Influenza like illness, Pain, Pyrexia
Clinical narrative: Other than getting severely sick with flu like symptoms (fever, aches, chills, extreme fatigue) - the sickest I have been in YEARS which lasted several days, I have had ongoing issues with my heart ever since.  Aching, odd sensations occurring there at any time of day, under any type of activity - even laying in bed & it will wake me up from my sleep at times.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Sensory disturbance, Sleep disorder
Clinical narrative: Other than getting severely sick with flu like symptoms (fever, aches, chills, extreme fatigue) - the sickest I have been in YEARS which lasted several days, I have had ongoing issues with my heart ever since.  Aching, odd sensations occurring there at any time of day, under any type of activity - even laying in bed & it will wake me up from my sleep at times.
Age: 7.0
Sex: F
Vaccine: COVID19
Symptoms: Product preparation issue
Clinical narrative: Administered 0.2ml dose of undiluted vaccine
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Feeling abnormal, Immediate post-injection reaction, Impaired work ability, Muscle tightness
Clinical narrative: Patient reports adverse effect Johnson & Johnson COVID-19 vaccine that she received on November 22, 2021.  This vaccine was given because she had a previous adverse reaction to the Pfizer mRNA vaccine which was a bit more suspicious for an immediate hypersensitivity type reaction and so based on the CDC guidelines and allergy practice recommendations we discussed the risks and benefits of receiving the Johnson & Johnson COVID-19 vaccine and she wanted to proceed with this vaccination.    She reports pain immediately upon receiving the injection that resolved within 5 minutes or so.  She felt a little "off" at work for the remaining of the workday.  She felt like her jaw was sort of tight but otherwise cannot identify any specific problems.   In the car in the way home her friend noted that she had hive-like rash at her face and she also relates that she had hive like a rash at her chest and arms.  This was not pruritic however. This waxed and waned for a few hours and then was completely gone by the next day.  Upon returning home she also began to experience body aches.  Tried to have some dinner and immediately felt nausea.  She began vomiting around 6:30 PM and vomited multiple times until she feels as though there is nothing left to vomit.  She tried taking omeprazole and immediately vomited that up.  She was gagging and vomiting.  She also then began having diarrhea and later on in the evening and continued with intermittent vomiting anytime she would try to eat and loose stools for the rest of that week.  On day 3 of symptoms she began using Pedialyte and was able to hold down Pedialyte in small amounts.  By Saturday, so day 5 after her shot she began to feel essentially normal.  She is still experiencing intermittent nausea.  She lost 5 pounds.  She did not experience additional rash.  Did not experience swelling, difficulty breathing, cough, wheeze.  Prior to the vaccine she had taken 10 mg of loratadine and 1000 mg of acetaminophen.  She had to remain home from work for the rest of that week.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain, Retching, Urticaria, Vomiting
Clinical narrative: Patient reports adverse effect Johnson & Johnson COVID-19 vaccine that she received on November 22, 2021.  This vaccine was given because she had a previous adverse reaction to the Pfizer mRNA vaccine which was a bit more suspicious for an immediate hypersensitivity type reaction and so based on the CDC guidelines and allergy practice recommendations we discussed the risks and benefits of receiving the Johnson & Johnson COVID-19 vaccine and she wanted to proceed with this vaccination.    She reports pain immediately upon receiving the injection that resolved within 5 minutes or so.  She felt a little "off" at work for the remaining of the workday.  She felt like her jaw was sort of tight but otherwise cannot identify any specific problems.   In the car in the way home her friend noted that she had hive-like rash at her face and she also relates that she had hive like a rash at her chest and arms.  This was not pruritic however. This waxed and waned for a few hours and then was completely gone by the next day.  Upon returning home she also began to experience body aches.  Tried to have some dinner and immediately felt nausea.  She began vomiting around 6:30 PM and vomited multiple times until she feels as though there is nothing left to vomit.  She tried taking omeprazole and immediately vomited that up.  She was gagging and vomiting.  She also then began having diarrhea and later on in the evening and continued with intermittent vomiting anytime she would try to eat and loose stools for the rest of that week.  On day 3 of symptoms she began using Pedialyte and was able to hold down Pedialyte in small amounts.  By Saturday, so day 5 after her shot she began to feel essentially normal.  She is still experiencing intermittent nausea.  She lost 5 pounds.  She did not experience additional rash.  Did not experience swelling, difficulty breathing, cough, wheeze.  Prior to the vaccine she had taken 10 mg of loratadine and 1000 mg of acetaminophen.  She had to remain home from work for the rest of that week.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Weight decreased
Clinical narrative: Patient reports adverse effect Johnson & Johnson COVID-19 vaccine that she received on November 22, 2021.  This vaccine was given because she had a previous adverse reaction to the Pfizer mRNA vaccine which was a bit more suspicious for an immediate hypersensitivity type reaction and so based on the CDC guidelines and allergy practice recommendations we discussed the risks and benefits of receiving the Johnson & Johnson COVID-19 vaccine and she wanted to proceed with this vaccination.    She reports pain immediately upon receiving the injection that resolved within 5 minutes or so.  She felt a little "off" at work for the remaining of the workday.  She felt like her jaw was sort of tight but otherwise cannot identify any specific problems.   In the car in the way home her friend noted that she had hive-like rash at her face and she also relates that she had hive like a rash at her chest and arms.  This was not pruritic however. This waxed and waned for a few hours and then was completely gone by the next day.  Upon returning home she also began to experience body aches.  Tried to have some dinner and immediately felt nausea.  She began vomiting around 6:30 PM and vomited multiple times until she feels as though there is nothing left to vomit.  She tried taking omeprazole and immediately vomited that up.  She was gagging and vomiting.  She also then began having diarrhea and later on in the evening and continued with intermittent vomiting anytime she would try to eat and loose stools for the rest of that week.  On day 3 of symptoms she began using Pedialyte and was able to hold down Pedialyte in small amounts.  By Saturday, so day 5 after her shot she began to feel essentially normal.  She is still experiencing intermittent nausea.  She lost 5 pounds.  She did not experience additional rash.  Did not experience swelling, difficulty breathing, cough, wheeze.  Prior to the vaccine she had taken 10 mg of loratadine and 1000 mg of acetaminophen.  She had to remain home from work for the rest of that week.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Rash pruritic
Clinical narrative: Chest tightness, shortness of breath, itchy rash (quarter size bumps).
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Vaccination complication
Clinical narrative: Patient went to ER cause his arm was red. Er states its a reaction to the booster and possible infection. Patient was given antibiotic and pain medications.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient was given an expired Moderna vaccine.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Abortion spontaneous, Arthralgia, Chills, Exposure during pregnancy, Human chorionic gonadotropin decreased
Clinical narrative: I had positive pregnancy test 11/19/21. I had COVID booster  vaccine 11/29/21 with 12 hours of severe joint and muscle pain, 102 fever and shaking chills that occurred 12 hours after vaccination (treated with Tylenol) . I had first US 12/9 that showed gestational sac measuring 5 weeks when I should have been around 7 weeks pregnant. HCG started declining and miscarried 12/15. Time of vaccination is around the time my pregnancy stopped progressing.